Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

FDA Construction Plans Need 'Innovative Financing Options'

Executive Summary

Senate Appropriations Committee says agency should look for alternatives to adding more space at its White Oak campus.


Related Content

FDA's Savings Machine: The White Oak Conference Room
US FDA Headquarters Parking Problem May Create Security Risk
GDUFA: Review Costs Continued To Climb Once Formal Review Goals Began
'Cures' vs Funding: FDA Appropriations Bill Is Latest Battleground
FDA Talent Hunt: Is Recruiting From Academia Better Than Industry?
FDA’s Rent Is Too Damn High: Consolidated Labs Cost More Than Off-Campus Space
CBER To Pause Receipt Of Lot Release Samples During Move To White Oak





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst